Bristol-Myers Squibb
BMY
#189
Rank
S$137.63 B
Marketcap
S$67.61
Share price
0.38%
Change (1 day)
-11.11%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): S$3.89

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is S$3.85. In 2024 the company made an earnings per share (EPS) of S-$5.73 a decrease over its 2023 EPS that were of S$5.03.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$3.89-167.82%
2024S-$5.73-213.92%
2023S$5.0330.2%
2022S$3.86-6.04%
2021S$4.11-179.29%
2020S-$5.19-281.37%
2019S$2.86-27.21%
2018S$3.93
2016S$3.46175.26%
2015S$1.26-19.83%
2014S$1.57-22.44%
2013S$2.0234.48%
2012S$1.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$2.23-42.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.84 155.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$26.60 590.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.54 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
S$4.80 24.77%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
S$3.93 2.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
S$13.53 251.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$1.75-54.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$16.89 338.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$14.25 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA